HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

N- (3,4- difluoro- 2- (2- fluoro- 4- iodophenylamino)- 6- methoxyphenyl)- 1- (2,3- dihydroxypropyl)cyclopropane- 1- sulfonamide

a MEK inhibitor; structure in first source
Also Known As:
BAY 869766; BAY-869766; BAY869766; RDEA 119; RDEA-119; RDEA119
Networked: 8 relevant articles (1 outcomes, 0 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Xing, Mingzhao: 3 articles (01/2012 - 02/2010)
2. Miner, Jeffrey N: 2 articles (01/2010 - 09/2009)
3. Choudry, Haroon A: 1 article (10/2015)
4. Song, Xinxin: 1 article (10/2015)
5. Dilly, Ashok K: 1 article (10/2015)
6. Guo, Zong S: 1 article (10/2015)
7. Zeh, Herbert J: 1 article (10/2015)
8. Lee, Yong J: 1 article (10/2015)
9. Bartlett, David L: 1 article (10/2015)
10. Hartmayer, Carmen: 1 article (05/2013)

Related Diseases

1. Neoplasms (Cancer)
2. Thyroid Neoplasms (Thyroid Cancer)
3. Pancreatic Neoplasms (Pancreatic Cancer)
4. Melanoma (Melanoma, Malignant)
5. Carcinoma (Carcinomatosis)

Related Drugs and Biologics

1. N- (3,4- difluoro- 2- (2- fluoro- 4- iodophenylamino)- 6- methoxyphenyl)- 1- (2,3- dihydroxypropyl)cyclopropane- 1- sulfonamide
2. AZD 6244
3. temsirolimus
4. D 21266 (perifosine)
5. Histone Deacetylase Inhibitors
6. Oseltamivir (Tamiflu)
7. Mitogen-Activated Protein Kinase Kinases (MEKs)
8. Sirolimus (Rapamycin)
9. Phosphotransferases (Kinase)
10. PD 0325901

Related Therapies and Procedures

1. Heterologous Transplantation (Xenotransplantation)